Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jul 28, 2017; 23(28): 5216-5228
Published online Jul 28, 2017. doi: 10.3748/wjg.v23.i28.5216
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5: Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 Rate of responders based on a “residual symptom rate ≤ 50%” definition after 4 wk of proton pump inhibitor therapy.
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 Distribution of patient’s impressions of therapy (Q11) and the rate of responders based on a “patient’s impression of improved or better” definition after 4 wk of proton pump inhibitor therapy.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Distribution of numeric rating scale scores (Q12) and the rate of responders based on a “numeric rating scale ≤ 5” definition after 4 wk of proton pump inhibitor therapy.
Figure 5
Open in New Tab Full Size Figure Download Figure
Figure 5 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores of responders and non-responders based on a “residual symptom rate ≤ 50%” definition at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5: Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.
Figure 6
Open in New Tab Full Size Figure Download Figure
Figure 6 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores of responders and non-responders based on a “patient’s impression of improved or better” definition at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5; Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.
Figure 7
Open in New Tab Full Size Figure Download Figure
Figure 7 Changes in the gastroesophageal reflux and dyspepsia-therapeutic efficacy and satisfaction test scores of responders and non-responders based on a “numeric rating scale ≤ 5” definition at baseline and after 4 wk of proton pump inhibitor therapy. Q1: Heartburn; Q2: Regurgitation; Q3: Epigastric pain/burning; Q4: Postprandial fullness; Q5: Early satiation; Q6: Dissatisfaction with eating; Q7: Dissatisfaction with sleeping; Q8: Dissatisfaction with daily activity; Q9: Dissatisfaction with mood. DS-SS: Dissatisfaction with daily life subscale.